Moderna @moderna_tx · 19 Aug 2026
Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage https://t.co/oaVDmxeHmx
99 791Views
638Likes
99Reposts
0Replies
23Quotes
52Bookmarks
Is that a lot?
1.08×vs this author's median92 367 views is typical
60Percentile for this authorof 5 recent posts
11.2×vs 100K–1M median8 935 views is typical
68.61%Reachviews ÷ followers
0.76%Engagement rateof viewers reacted